Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transabdominal Amnioinfusion for Improving Fetal Outcomes After Oligohydramnios Secondary to Preterm Prelabour Rupture of Membranes Before 26 Weeks: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432677/all/Mannitol_and_other_osmotic_diuretics_as_adjuncts_for_treating_cerebral_malaria_Unchanged. Accessed 30 November 2023.
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432677/all/Mannitol_and_other_osmotic_diuretics_as_adjuncts_for_treating_cerebral_malaria_Unchanged. Accessed November 30, 2023.
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432677/all/Mannitol_and_other_osmotic_diuretics_as_adjuncts_for_treating_cerebral_malaria_Unchanged
Transabdominal Amnioinfusion for Improving Fetal Outcomes After Oligohydramnios Secondary to Preterm Prelabour Rupture of Membranes Before 26 Weeks: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432677/all/Mannitol_and_other_osmotic_diuretics_as_adjuncts_for_treating_cerebral_malaria_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks: Cochrane systematic review
ID - 432677
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432677/all/Mannitol_and_other_osmotic_diuretics_as_adjuncts_for_treating_cerebral_malaria_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -